Binosto Dosage
Generic name: ALENDRONATE SODIUM 91.37mg
Dosage form: tablet, effervescent
Drug class: Bisphosphonates
Medically reviewed by Drugs.com. Last updated on Feb 24, 2025.
Treatment of Osteoporosis in Postmenopausal Women
The recommended dosage is one 70 mg effervescent tablet once weekly.
Treatment to Increase Bone Mass in Men With Osteoporosis
The recommended dosage is one 70 mg effervescent tablet once weekly.
Important Administration Instructions
Instruct patients to do the following to assure adequate drug absorption and to decrease the risk of esophageal adverse reactions:
- i.
- Take BINOSTO upon arising for the day and at least 30 minutes before the first food, beverage, or medication of the day.
- Patients should not swallow the undissolved effervescent tablet, should not chew the effervescent tablet or allow the effervescent tablet to dissolve in their mouths because of the risk for oropharyngeal irritation.
Dissolve the effervescent tablet in 4 ounces room temperature plain water only (not mineral water or flavored water).
- Patients should not swallow the undissolved effervescent tablet, should not chew the effervescent tablet or allow the effervescent tablet to dissolve in their mouths because of the risk for oropharyngeal irritation.
- ii.
- Wait at least 5 minutes after the effervescence stops and then stir the buffered solution for approximately 10 seconds and ingest.
- iii.
- Avoid lying down for at least 30 minutes after taking BINOSTO and until after their first food of the day.
- iv.
- Do not take BINOSTO at bedtime or before arising for the day.
Failure to follow these instructions may increase the risk of esophageal adverse reactions.
Recommendations for Calcium and Vitamin D Supplementation
Instruct patients to take supplemental calcium and vitamin D if dietary intake is inadequate. Patients at increased risk for vitamin D insufficiency (e.g., over the age of 70 years, nursing home-bound, or chronically ill) may need vitamin D supplementation. Patients with gastrointestinal malabsorption syndromes may require higher doses of vitamin D supplementation and measurement of 25-hydroxyvitamin D should be considered.
Frequently asked questions
More about Binosto (alendronate)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: bisphosphonates
- Breastfeeding
- En español
Patient resources
Other brands
Professional resources
Other brands
Related treatment guides
See also:
Prolia
Prolia (denosumab) is an injection that is administered subcutaneously (under the skin) once every ...
Fosamax
Fosamax (alendronate) is used to treat or prevent postmenopausal osteoporosis and steroid-induced ...
Evenity
Evenity (romosozumab) injection is used to treat osteoporosis in postmenopausal women to reduce the ...
Premarin
Premarin is used to treat symptoms of menopause such as hot flashes, and vaginal dryness. Learn ...
Reclast
Reclast (zoledronic acid) is used to treat osteoporosis in women after menopause and also to treat ...
Estrace
Estrace (estradiol) is used to treat symptoms of menopause such as hot flashes and vaginal dryness ...
Raloxifene
Raloxifene systemic is used for breast cancer, prevention, osteoporosis, prevention of osteoporosis
Denosumab
Denosumab (Prolia, Conexxence, Jubbonti, Ospomyv, and Stoboclo brands/biosimilars) is used to treat ...
Calcium/vitamin d
Calcium/vitamin d systemic is used for dietary supplementation, osteoporosis
Calcium carbonate
Calcium carbonate systemic is used for duodenal ulcer, erosive esophagitis, GERD, hypocalcemia ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.